339 related articles for article (PubMed ID: 33958859)
1. Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment.
Meirelles I; Magliano C
Patient Prefer Adherence; 2021; 15():911-917. PubMed ID: 33958859
[TBL] [Abstract][Full Text] [Related]
2. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
[TBL] [Abstract][Full Text] [Related]
3. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
4. Patient Preferences For Chemotherapy In The Treatment Of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study In China.
Sun H; Wang H; Xu N; Li J; Shi J; Zhou N; Ni M; Hu X; Chen Y
Patient Prefer Adherence; 2019; 13():1701-1709. PubMed ID: 31631985
[TBL] [Abstract][Full Text] [Related]
5. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
Monzani D; Petrocchi S; Oliveri S; Veldwijk J; Janssens R; Bailo L; Smith MY; Smith I; Schoefs E; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Katz EG; Petrella F; Casiraghi M; Durosini I; Galli G; Garassino MC; de Wit GA; Pravettoni G; Huys I
Front Med (Lausanne); 2021; 8():689114. PubMed ID: 34409049
[No Abstract] [Full Text] [Related]
6. Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Bruni C; Heidenreich S; Duenas A; Hoffmann-Vold AM; Gabrielli A; Allanore Y; Chatelus E; Distler JHW; Hachulla E; Hsu VM; Hunzelmann N; Khanna D; Truchetet ME; Walker UA; Alves M; Schoof N; Saketkoo LA; Distler O
Rheumatology (Oxford); 2022 Oct; 61(10):4035-4046. PubMed ID: 35238334
[TBL] [Abstract][Full Text] [Related]
7. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
[TBL] [Abstract][Full Text] [Related]
8. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
9. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
[TBL] [Abstract][Full Text] [Related]
10. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
[TBL] [Abstract][Full Text] [Related]
11. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
[TBL] [Abstract][Full Text] [Related]
12. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
[TBL] [Abstract][Full Text] [Related]
13. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.
Sun H; Wang H; Shi L; Wang M; Li J; Shi J; Ni M; Hu X; Chen Y
BMJ Open; 2020 Feb; 10(2):e032336. PubMed ID: 32051302
[TBL] [Abstract][Full Text] [Related]
14. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis.
Bridges JF; Mohamed AF; Finnern HW; Woehl A; Hauber AB
Lung Cancer; 2012 Jul; 77(1):224-31. PubMed ID: 22369719
[TBL] [Abstract][Full Text] [Related]
15. Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment.
Yong C; Cambron-Mellott MJ; Seal B; Will O; Maculaitis MC; Clapp K; Mulvihill E; Cotarla I; Mehra R
Patient Prefer Adherence; 2022; 16():123-135. PubMed ID: 35068928
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
[TBL] [Abstract][Full Text] [Related]
17. The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.
Lloyd A; McIntosh E; Price M
Pharmacoeconomics; 2005; 23(11):1167-81. PubMed ID: 16277551
[TBL] [Abstract][Full Text] [Related]
18. Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer.
Mühlbacher AC; Bethge S
Eur J Health Econ; 2015 Jul; 16(6):657-70. PubMed ID: 25135768
[TBL] [Abstract][Full Text] [Related]
19. Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States.
Feldman SR; Holmen Moeller A; Erntoft Idemyr ST; González JM
J Health Econ Outcomes Res; 2017; 4(2):141-157. PubMed ID: 37661952
[No Abstract] [Full Text] [Related]
20. Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in Japan.
Sugitani Y; Ito K; Ono S
Front Pharmacol; 2021; 12():697711. PubMed ID: 34354590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
